We report a case of a 56-year-old man requiring a HeartMate 3 after a myocardial infarction and limited recovery on a temporary ventricular assist device. Because of several gastrointestinal bleeding complications and nonadherence, his antithrombotic therapy was switched from warfarin and aspirin to apixaban 5 mg twice daily. We also determined several peak anti-factor Xa levels for ongoing monitoring. Direct oral anticoagulants may be an option for the prevention of pump thrombosis in patients who are unable to tolerate or refuse warfarin therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708617 | PMC |
| http://dx.doi.org/10.1016/j.atssr.2023.09.014 | DOI Listing |
Publication Analysis
Top Keywords
ventricular assist
8
assist device
8
anticoagulation heartmate
4
heartmate left
4
left ventricular
4
device apixaban
4
apixaban report
4
report case
4
case 56-year-old
4
56-year-old man
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!